GlobalData on MSN2d
Nevro obtains FDA approval for AI-based spinal cord stimulation system
Medical device company Nevro has received approval from the US Food and Drug Administration (FDA) and announced a limited ...
MassDevice2d
Nevro wins FDA nod for AI-driven spinal cord stimulation tech
Nevro announced today that it received FDA approval for an AI-powered, personalized pain management platform for spinal cord ...
Becker's Spine Review2d
Nevro launches AI-powered spinal cord stimulator
Nevro earned FDA approval and began a limited market release of its HFX iQ spinal cord stimulator with HFX AdaptivAI, the company said Sept. 24.
Yahoo Finance3d
Nevro Announces the Launch of HFX AdaptivAI™, the Only AI-Driven Technology in Spinal Cord Stimulation
personalized pain management platform powering the HFX iQ spinal cord stimulation (SCS) system. Building on a foundation of ...
NeuroOne® Spinal Cord Stimulation Electrode Technology to be Featured at The Business of Pain Conference
Minimally invasive technology would allow for percutaneous placement of a paddle electrodeRenowned pain specialist Dr. Sean Li to present on this ...
Zacks.com on MSN1d
NVRO Stock May Gain on the FDA Approval of Its HFX AdaptivAI Platform
Nevro NVRO recently announced the FDA clearance and limited market release of HFX iQ with HFX AdaptivAI, a responsive, ...
eLife2d
Identification of pharmacological inducers of a reversible hypometabolic state for whole organ preservation
Repurposing of a drug designed for pain relief can quickly and reversibly slow biochemical and metabolic activities in cells and organs and could facilitate organ transplantation and prevent tissue ...